Eisai to work with Tokio towards prevention of dementia

Japan |  News | 0 Comment | 30 Sep, 2019

Japanese firm Eisai Co., Ltd. and Tokio Marine & Nichido Fire Insurance Co., Ltd. have announced that the companies have entered into a business alliance agreement for co-existence and ...Read more

Eisai, Fronteo launch Coroban prediction system for inpatients

Japan |  News | 0 Comment | 27 Sep, 2019

Eisai Co., Ltd. and FRONTEO, Inc. have launched the tumbling and falling prediction system Coroban to medical institutions in Japan. The Coroban predicts inpatients' tumbling and falling ri...Read more

AGC Biologics appoints new General Manager for Japan

Japan |  News | 0 Comment | 26 Sep, 2019

AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced the appointment of Naofumi Kagami as Site Head/General Manager of the&nb...Read more

Noven Announces Appointment of Dr. Naruhito Higo as CEO

Japan |  News | 0 Comment | 24 Sep, 2019

Noven Pharmaceutical has announced its decision to appoint Dr. Naruhito Higo as Chief Executive Officer effective October 1, 2019, succeeding Jeff Mihm who has tendered his resignation...Read more

Eisai, Meiji receive approval for Parkinson's drug

Japan |  News | 0 Comment | 24 Sep, 2019

Eisai Co., Ltd. and Meiji Seika Pharma Co., Ltd. have announced the manufacturing and marketing approval in Japan for the indication of improvement of wearing-off phenomenon in patients wit...Read more

Takeda receives Ministry approval for depression drug

Japan |  News | 0 Comment | 23 Sep, 2019

Japanese firm Takeda Pharmaceutical Company Limited  and Denmark based H. Lundbeck A/S jointly announced that the Ministry of Health, Labour and Welfare (MHLW) of Japan approved Trinte...Read more

Evrenzo gets approval in Japan to treat anemia associated with CKD

Japan |  News | 0 Comment | 20 Sep, 2019

Astellas Pharma Inc. and FibroGen, Inc. have announced that Japan's Ministry of Health, Labour and Welfare (MHLW) approved Evrenzo® (generic name: roxadustat) for the tre...Read more

Kao named to the Dow Jones Sustainability World Index

Japan |  News | 0 Comment | 20 Sep, 2019

Kao Corporation has been selected for inclusion in the 2019 Dow Jones Sustainability World Index (DJSI World) and Dow Jones Sustainability Asia Pacific Index (DJSI Asia Pacific), among the ...Read more

Japan's Solasia set to start trials for Darinaparsin

Japan |  News | 0 Comment | 20 Sep, 2019

Solasia Pharma KK has  announced that the darinaparsin Phase 2 study patient registration has reached the target number of cases. The Phase 2 study was a multinational, single-gr...Read more

FDA approves combo drug to treat endometrial carcinoma

Japan |  News | 0 Comment | 19 Sep, 2019

Eisai and Merck have announced that the U.S. Food and Drug Administration (FDA) approved the combination of LENVIMA, the orally available kinase inhibitor discovered by Eisai, plus KEYTRUDA...Read more

Toyobo to market RNA analysis kit based on RIKEN technology

Japan |  News | 0 Comment | 19 Sep, 2019

Japan headquartered Toyobo Co., Ltd. has productized a ribonucleic acid (RNA) analysis kit based on a novel system titled RamDA-seq, that allows full-length sequencing of the total RNA of a...Read more

Mitsubishi Tanabe, Daiichi Sankyo tie alliance for ALS treatment agent

Japan |  News | 2 Comment | 18 Sep, 2019

Mitsubishi Tanabe Pharma Corporation and Daiichi Sankyo Company Limited have announced that they have concluded a licensing agreement covering commercialization rights in Brazil for an intr...Read more

Seattle Genetics, Astellas gets USFDA priority review for Enfortumab Vedotin

Japan |  News | 0 Comment | 17 Sep, 2019

Seattle Genetics, Inc. and Astellas Pharma Inc. have announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for the investigati...Read more

Astellas, iota Biosciences enter into collaborative R&D agreement

Japan |  News | 0 Comment | 17 Sep, 2019

Japanese firm Astellas Pharma and iota Biosciences, Inc. have announced a joint research and development agreement to explore new biosensing and treatment measures using ultra-sma...Read more

Eisai, Biogen discontinue clinical studies on AD drug candidate

Japan |  News | 0 Comment | 16 Sep, 2019

Japan headquartered Eisai Co., Ltd. and US based Biogen Inc. have announced the decision to discontinue the Phase III clinical studies (MISSION AD1, AD2) on the investigational oral BACE (b...Read more

Astellas to accelerate early drug discovery

Japan |  News | 0 Comment | 13 Sep, 2019

Astellas Venture Management, LLC, a wholly-owned venture capital subsidiary of Japan based Astellas Pharma Inc., and US based Mission Bay Capital BioLabs, a life-science incubator, have ann...Read more

Chugai Presents Results from Second Positive Global Phase III Clinical Study of Satralizumab

Japan |  News | 0 Comment | 12 Sep, 2019

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced that the results from SAkuraStar Study were presented at the Congress of European Committee for Treatment and Research in Multipl...Read more

Daiichi Sankyo brings new formulation for cancer pain treatment

Japan |  News | 0 Comment | 12 Sep, 2019

Daiichi Sankyo Company Limited has announced it has launched a new generic formulation of oxycodone hydrochloride hydrate extended release tablets for sustained cancer pain treatment in Jap...Read more